The overall survival and chemotherapy response of LSCC patients have been predicted by models consisting of histopathological factors (CA199, CA724), genes (CD48, CD2) [18], radiomics [19], and clinical factors (tumor differentiation, age, and stage) [20]. This evidence concerns the gene CD2 and neoplasm.